|
| |
| | | 56148 | | 15.07.2004 | | Ipsen Pharma Schweiz GmbH | | 31.12.2004 | | | | | | | | | | | 07.16.20. | | | | 07.16.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Somatuline Autogel 60 mg | Injektionslösung | Injection solution (Lanreotide 60 mg) | H01CB03 | CI | | 02 | Somatuline Autogel 90 mg | Injektionslösung | Injection solution (Lanreotide 90 mg) | H01CB03 | CI | | 03 | Somatuline Autogel 120 mg | Injektionslösung | Injection solution (Lanreotide 120 mg) | H01CB03 | CI |
|
|
|
